Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
906.71
-7.66 (-0.84%)
At close: Jul 2, 2024, 4:00 PM
910.50
+3.79 (0.42%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Eli Lilly Revenue
Eli Lilly had revenue of $35.93B in the twelve months ending March 31, 2024, with 29.76% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $8.77B with 25.98% year-over-year growth. In the year 2023, Eli Lilly had annual revenue of $34.12B with 19.56% growth.
Revenue (ttm)
$35.93B
Revenue Growth
+29.76%
P/S Ratio
23.98
Revenue / Employee
$835,630
Employees
43,000
Market Cap
861.74B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | 22.32B | 826.20M | 3.84% |
Dec 31, 2018 | 21.49B | 1.52B | 7.61% |
Dec 31, 2017 | 19.97B | -1.25B | -5.88% |
Dec 31, 2016 | 21.22B | 1.26B | 6.33% |
Dec 31, 2015 | 19.96B | 343.10M | 1.75% |
Dec 31, 2014 | 19.62B | -3.50B | -15.13% |
Dec 31, 2013 | 23.11B | 509.70M | 2.25% |
Dec 31, 2012 | 22.60B | -1.68B | -6.93% |
Dec 31, 2011 | 24.29B | 1.21B | 5.25% |
Dec 31, 2010 | 23.08B | 1.24B | 5.68% |
Dec 31, 2009 | 21.84B | 1.46B | 7.19% |
Dec 31, 2008 | 20.37B | 1.74B | 9.33% |
Dec 31, 2007 | 18.63B | 2.94B | 18.75% |
Dec 31, 2006 | 15.69B | 1.05B | 7.14% |
Dec 31, 2005 | 14.65B | 787.40M | 5.68% |
Dec 31, 2004 | 13.86B | 1.28B | 10.14% |
Dec 31, 2003 | 12.58B | 1.51B | 13.59% |
Dec 31, 2002 | 11.08B | -465.00M | -4.03% |
Dec 31, 2001 | 11.54B | 680.30M | 6.26% |
Dec 31, 2000 | 10.86B | 859.30M | 8.59% |
Dec 31, 1999 | 10.00B | 766.10M | 8.29% |
Dec 31, 1998 | 9.24B | 1.25B | 15.64% |
Dec 31, 1997 | 7.99B | 989.40M | 14.14% |
Dec 31, 1996 | 7.00B | 234.50M | 3.47% |
Dec 31, 1995 | 6.76B | 1.05B | 18.42% |
Dec 31, 1994 | 5.71B | 513.10M | 9.87% |
Dec 31, 1993 | 5.20B | 235.40M | 4.74% |
Dec 31, 1992 | 4.96B | -762.60M | -13.32% |
Dec 31, 1991 | 5.73B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
LLY News
- 6 hours ago - Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices - Investopedia
- 8 hours ago - Eli Lilly's Alzheimer's drug wins FDA approval - Market Watch
- 9 hours ago - FDA Approves Eli Lilly's Alzheimer's Drug Donanemab - Forbes
- 9 hours ago - FDA approves Eli Lilly Alzheimer's drug, expanding treatment options in the U.S. - CNBC
- 9 hours ago - US FDA approves Lilly's Alzheimer's drug - Reuters
- 9 hours ago - Approval of Newest Alzheimer's Drug Will Accelerate New Era of Treatment - WSJ
- 10 hours ago - Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease - PRNewsWire
- 12 hours ago - Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs - Benzinga